Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer
Authors
Keywords
-
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-13
DOI
10.1007/s12253-020-00865-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colon Cancer Sidedness, Presentation, and Survival at Different Stages
- (2019) Mark B. Ulanja et al. Journal of Oncology
- 18F-FDG PET/CT imaging in rectal cancer: relationship with theRASmutational status
- (2016) Pierre Lovinfosse et al. BRITISH JOURNAL OF RADIOLOGY
- Early Prediction by 18F-FDG PET/CT for Progression-Free Survival and Overall Survival in Patients With Metastatic Colorectal Cancer Receiving Third-Line Cetuximab-Based Therapy
- (2015) Feng-Yuan Liu et al. CLINICAL NUCLEAR MEDICINE
- Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
- (2015) S.Y. Brulé et al. EUROPEAN JOURNAL OF CANCER
- Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
- (2015) Fotios Loupakis et al. JNCI-Journal of the National Cancer Institute
- Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
- (2015) Fotios Loupakis et al. JNCI-Journal of the National Cancer Institute
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Positron Emission Tomography/Computed Tomography and Biomarkers for Early Treatment Response Evaluation in Metastatic Colon Cancer
- (2014) B. E. Engelmann et al. ONCOLOGIST
- Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases
- (2013) Jeroen Mertens et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS/BRAF Mutations in Colorectal Cancer
- (2012) K. Kawada et al. CLINICAL CANCER RESEARCH
- Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
- (2012) Jacques-Antoine Maisonobe et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer
- (2012) Irène Buvat et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intermodality comparison between 3D perfusion CT and 18F-FDG PET/CT imaging for predicting early tumor response in patients with liver metastasis after chemotherapy: Preliminary results of a prospective study
- (2012) Dong Hyun Kim et al. EUROPEAN JOURNAL OF RADIOLOGY
- The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus
- (2012) R. Adam et al. ONCOLOGIST
- Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
- (2011) A. Hendlisz et al. ANNALS OF ONCOLOGY
- Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer
- (2009) P. Bystrom et al. ANNALS OF ONCOLOGY
- Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
- (2009) L.-F. de Geus-Oei et al. JOURNAL OF NUCLEAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search